X-Factor - Arachidon

Clinically tested at Baylor University for safety and effectiveness, Molecular Nutrition’s Anabolic X-Factor™ is the world’s first patented hypertrophic catalyst. By enhancing the storage of arachidonic acid in exercised muscles, X-Factor drastically amplifies the body’s sensitivity and responsiveness to resistance training. This means faster and more profound increases in muscle size, strength, even the rate of lipolysis (fat loss). Clinical trials at the Exercise & Sport Nutrition Lab at Baylor University have demonstrated remarkable increases in muscle strength (44% > placebo), peak muscle power (600% > placebo), average power (223% > placebo), and anaerobic endurance (250% > placebo) with 50 days of X-Factor supplementation. Having passed the ultimate test of clinical investigation and peer-review, X-Factor joins the elite ranks of a select few clinically proven ergogenic agents.

X-Factor is safe

With extensive monitoring of various biomarkers of health, the clinical trails at Baylor University established not only that X-Factor is an effective performance-enhancing supplement, but that it is safe supplement as well. Subjects taking X-Factor noticed no negative changes in any of the markers of clinical safety, nor were any side effects ever recorded. Furthermore, serum levels of inflammatory marker IL-6 (interleukin-6) tended to strongly decline in the X-Factor group, which demonstrates a potential beneficial reduction of systemic (whole-body) inflammation.

Recommended Use

Take 4 capsules per day if you are 200lbs or over, and 3 capsules daily if you are under. The capsules can be taken with meals, and are best divided into 3 or 4 separate applications (1 capsule, 3-4 times per day). Take for 50 days, followed by a break of at least 50 days. Because X-Factor intensifies protein turnover in exercised muscles, you may need to increase your total daily protein and calorie intake in order to gain significant muscle bulk. This often falls in the range of a 500-1000 calorie per day increase.